Biosimilars Market Research Reports & Industry Analysis
The worldwide prescription generic drug market has stood the test of time and has endured numerous growing pains. However, it has evolved into a formidable and important participant in the complex world of health care. Generic drugs continue to represent one of the greatest values in healthcare and are of great importance in the area of biopharmaceuticals as well because these products are among the most expensive treatments currently on the market.
Generic drug manufacturers are poised for strong growth in the future because the patent protection for a host of major biopharmaceuticals will expire and new legislative reforms in the generic drug approval process may facilitate bringing products to market. While there are many issues to address, the outlook for the promotion of biosimilars is favorable in the next five years.
Biosimilars Industry Research & Market Reports
-
Biosimilar Market Report by Molecule (Infliximab, Insulin Glargine, Epoetin Alfa, Etanercept, Filgrastim, Somatropin, Rituximab, Follitropin Alfa, Adalimumab, Pegfilgrastim, Trastuzumab, Bevacizumab, and Others), Indication (Auto-Immune Diseases, Blood Disorders, Diabetes, Oncology, Growth Deficiency, Female Infertility, and Others), Manufacturing Type (In-house Manufacturing, Contract Manufacturing), and Region 2025-2033
... Manufacturing Type (In-house Manufacturing, Contract Manufacturing), and Region 2025-2033 The global biosimilar market size reached USD 26.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 185.1 Billion by 2033, exhibiting ... Read More
-
2025 Global Forecast for Biosimilars Market (2026-2031 Outlook)-High Tech Outlook Report
... service category is within the NAICS Medical Device Mfg. industry. The product or service category is within the NAICS Medical Device Mfg. industry. The global market is expected to increase from USD xx billion in ... Read More
-
2025 Global Forecast for Biologics And Biosimilars Market (2026-2031 Outlook)-High Tech Outlook Report
... product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in ... Read More
-
2025 Global Forecast for Biosimilar Monoclonal Antibodies Market (2026-2031 Outlook)-High Tech Outlook Report
... product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in ... Read More
-
2025 Global Forecast for Bevacizumab Biosimilar Market (2026-2031 Outlook)-High Tech Outlook Report
... or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in 2026 ... Read More
-
2025 Global: Bevacizumab Biosimilar Market - Innovative Markets Forecast (2031) report
... forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2020 to 2031 using regression analysis in our modeling. and Perry/Hope is the only market research ... Read More
-
2025 Global: Biologics And Biosimilars Market - Innovative Markets Forecast (2031) report
... industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2020 to 2031 using regression analysis in our modeling. and Perry/Hope is the only market ... Read More
-
U.S. Pharmaceutical Third-party Logistics Services Market Size, Share & Trends Analysis Report By Product Type (Branded, Cell Therapy, Biosimilar), By Temperature (Ambient, Refrigerated), By Therapeutic Area, By Manufacturer Size, By Service, And Segment Forecasts, 2025 - 2030
... of 8.90% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is driven due to the growing demand for efficient and secure supply chain solutions, increasing complexity in ... Read More
-
Global Tumor Necrosis Factor Inhibitor Drugs Market Size Study by Product (Humira, Enbrel, Remicade, Simponi/Simponi Aria, Cimzia, Biosimilars), by Application (Rheumatoid Arthritis, Psoriasis, Ulcerative Colitis, Crohn’s Disease, and Others), by Sales Channel (Hospital Pharmacy, Specialty Pharmacy, Online Pharmacy), and Regional Forecasts 2022-2032
... Pharmacy, Online Pharmacy), and Regional Forecasts 2022-2032 TNF inhibitors are pivotal in treating autoimmune and inflammatory conditions, including rheumatoid arthritis, psoriasis, and Crohn’s disease, by targeting and inhibiting the action of tumor necrosis factor, a ... Read More
-
PEGylated Proteins Market Report by Product (Consumables, Services), Protein Type (Colony Stimulating Factors, Interferons, Erythropoietin, mAbs, Recombinant Factor VII, and Others), Application (Cancer Treatment, Hepatitis, Chronic Kidney Diseases, Hemophilia, Multiple Sclerosis, Gastrointestinal Disorders, and Others), End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic and Research Institutes), and Region 2025-2033
... End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic and Research Institutes), and Region 2025-2033 The global PEGylated proteins market size reached USD 1.4 Billion in 2024. Looking forward, IMARC Group expects the market ... Read More
-
U.S. Pharmaceutical Packaging Services Market Size, Share & Trends Analysis Report By Product (Branded, Generic, Biosimilar, Vaccine, Cell Therapy, Gene Therapy), By Service Line, By Manufacturer Size, And Segment Forecasts, 2025 - 2030
... 2025 to 2030, according to a new report by Grand View Research, Inc. The U.S. pharmaceutical industry is heavily regulated by agencies such as the Food and Drug Administration (FDA), which mandates strict packaging guidelines ... Read More
-
Global High Potency APIs Market Size study, by Type (Innovative, Generic), by Type of Synthesis (Synthetic, Biotech, Biosimilars, mAbs, Vaccines), by Manufacturers (Captive, Merchant), by Application (Oncology, Hormonal Imbalance, Glaucoma) and Regional Forecasts 2022-2032
... global High Potency APIs (HPAPIs) market is currently valued at approximately USD 26.97 billion in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 10.10% during the forecast period from ... Read More
-
2025 Global Forecast for Biosimilar Contract Manufacturing Market (2026-2031 Outlook)-High Tech Outlook Report
... service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in 2026 to ... Read More
-
Psoriasis Biosimilars Market Forecasts to 2030 – Global Analysis By Product (Tumor Necrosis Factor (TNF) Inhibitors, Interleukin Inhibitors, Rituximab Biosimilars, Etanercept Biosimilars and Other Products), Therapy Type, Application, End User and By Geography
... Stratistics MRC, the Global Psoriasis Biosimilars Market is accounted for $10.27 billion in 2024 and is expected to reach $25.31 billion by 2030 growing at a CAGR of 12.2% during the forecast period. Psoriasis biosimilars ... Read More
-
Global Avastin (Bevacizumab) Biosimilars Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
... in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period. Avastin (Bevacizumab) is a medication used to treat a number of types of ... Read More
-
Global Avastin (Bevacizumab) Biosimilars Market Growth 2024-2030
... the Avastin (Bevacizumab) Biosimilars is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Avastin (Bevacizumab) ... Read More
-
Global G-CSF Biosimilars Market Growth 2024-2030
... Biosimilars is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global G-CSF Biosimilars market. G-CSF Biosimilars ... Read More
-
Global HGH Biosimilars Market Growth 2024-2030
... Biosimilars is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global HGH Biosimilars market. HGH Biosimilars ... Read More
-
Global Insulin Biosimilars Market Growth 2024-2030
... Insulin Biosimilars is forecast to a readjusted size of US$ 1858.4 million by 2030 with a CAGR of 3.6% during review period. The research report highlights the growth potential of the global Insulin Biosimilars market. ... Read More
-
Biosimilars Market Outlook Report: Industry Size, Market Shares Data, Latest Trends, Insights, Growth Potential, CAGR Forecasts to 2034
... CAGR to reach market size worth USD 117.1 billion by 2034. The biosimilars market is experiencing a period of rapid growth and evolution, driven by the increasing demand for affordable alternatives to expensive biologic drugs. ... Read More
-
PEGylated Proteins Market Size, Share, By Type (Consumables, and Services), By Protein (Colony-stimulating factor, Interferons, Erythropoietin, Recombinant factor VII, and Other), By Application (Cancer, Autoimmune Disease, Hepatitis, Multiple Sclerosis, Hemophilia, Gastrointestinal Disorder, and Others), By End-User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, and Academic and Research Institutes), and By Region - Trends, Analysis and Forecast till 2034
... End-User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, and Academic and Research Institutes), and By Region - Trends, Analysis and Forecast till 2034 PEGylated Proteins Market is experiencing significant growth, driven by increasing demand for ... Read More
-
Global Monoclonal antibodies (mAbs) Biosimilars Market Growth (Status and Outlook) 2024-2030
... With growing demand in downstream market, the Monoclonal antibodies (mAbs) Biosimilars is forecast to a readjusted size of US$ 5256.8 million by 2030 with a CAGR of 2.0% during review period. The research report highlights ... Read More
-
Bioprocess Technology Market Size, Share & Trends Analysis Report By Product Type (Biologics Safety Testing, Cell Culture, Cell Line Development, Cell Expansion, Flow Cytometry, Tangential Flow Filtration, Others), By Applications (Antibiotics, Biosimilars, Recombinant Proteins, Others), By End-User (Biopharmaceutical Companies, Contract Manufacturing Organization, Food and Feed Industry, Academic Research Institutes, Contract Research Organization, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2023-2031
... of 13.38% during the forecast period. The Global Bioprocess Technology Market Analysis report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It ... Read More
-
Global Biosimilars Insulin Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
... and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period. Biosimilars is a biological product designed to have similar active properties to the one that ... Read More
-
Rare Disease Treatment Market Assessment, By Drug Type [Biologics, Biosimilars, Small Molecules], By Patient [Adult, Pediatric, Geriatric], By Therapeutic Area [Oncology, Hematology, Neurology, Endocrinology, Cardiovascular, Respiratory, Immunotherapy, Infectious Diseases, Others], Mode of Administration [Oral, Injectable, Others], By Distribution Channel [Hospital Pharmacy, Retail Pharmacy, Online Pharmacy], By Region, Opportunities and Forecast, 2017-2031F
... Others], By Distribution Channel [Hospital Pharmacy, Retail Pharmacy, Online Pharmacy], By Region, Opportunities and Forecast, 2017-2031F Global hemophilia market is projected to witness a CAGR of 5.50% during the forecast period 2024-2031, growing from USD ... Read More
Research Assistance
